Evotec SE is a Germany-based biotechnology company that provides drug discovery and development services to pharmaceutical, biotechnology and academic partners. The company combines scientific expertise, technology platforms and proprietary research programs to support the identification and advancement of potential medicines.
Its activities span early-stage research and development, including target identification and validation, assay development, screening, medicinal chemistry, computational drug design, pharmacology and preclinical development. Evotec also works in areas such as neuroscience, metabolic disease, oncology, inflammation, infectious diseases and women's health, and may advance selected proprietary or partnered programs toward clinical development.
Founded in Hamburg in 1993, Evotec has expanded from a drug discovery provider into an integrated research and development partner with operations and collaborations across Europe and the United States. The company works with pharmaceutical companies, biotechnology firms, foundations and academic institutions through collaborative research agreements, alliances and fee-based services.
AI Generated. May Contain Errors.
